Is ketorolac safe for a breastfeeding mother, particularly in the early postpartum period, or should alternative analgesics be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketorolac Safety During Breastfeeding

Ketorolac is safe and compatible with breastfeeding, including in the early postpartum period, and can be used without interrupting nursing or discarding breast milk. 1, 2, 3

Evidence-Based Safety Profile

  • The Association of Anaesthetists explicitly lists ketorolac as a compatible NSAID for breastfeeding mothers, with no requirement to interrupt nursing or express and discard milk. 1, 2, 3

  • Ketorolac transfers into breast milk in very low concentrations without demonstrable adverse effects in the neonate. 3 The FDA label confirms that after a single 10 mg oral dose, the maximum milk concentration was only 7.3 ng/mL, with a milk-to-plasma ratio of 0.037. 4

  • The calculated maximum daily infant exposure is 0.00263 mg/kg/day, representing only 0.4% of the maternal weight-adjusted dose—well below the 10% safety threshold established for breastfeeding medications. 4

  • Levels were undetectable (less than 5 ng/mL) in 4 of 10 breastfeeding women studied 2–6 days postpartum. 4

Clinical Recommendations for Use

  • Breastfeeding can continue immediately after ketorolac administration without any waiting period. 3 Expressing and discarding breast milk is unnecessary and offers no safety benefit. 2

  • Use the lowest effective dose for the shortest duration needed, consistent with multimodal analgesia principles. 1, 2, 3

  • Ketorolac is recommended as a preferred option over opioids for breastfeeding women due to its favorable safety profile and lack of infant sedation or respiratory depression risk. 2, 3

  • Combining ketorolac with paracetamol (acetaminophen) provides effective multimodal analgesia while minimizing total NSAID exposure. 2, 5

Special Considerations for Young Infants

  • Extra caution is required for infants less than 6 weeks of age (corrected for gestational age) due to immature hepatic and renal function, though ketorolac remains a safe option even in this population. 3, 5

  • Preterm infants have the highest medication sensitivity, followed by neonates, then young infants. 2, 5

  • Monitor infants for any unusual signs (though adverse events have not been documented in the literature), and instruct mothers to contact their infant's healthcare provider if concerns arise. 4

Alternative Safe Analgesics

If ketorolac is contraindicated or unavailable, the following NSAIDs are equally safe during breastfeeding:

  • Ibuprofen is the first-line NSAID choice with the most reassuring safety data during lactation. 2, 5

  • Diclofenac is the second-safest NSAID option after ibuprofen. 2, 5

  • Naproxen is safe despite its longer half-life and is widely used postpartum. 2, 5

  • Paracetamol (acetaminophen) is equally safe and can be used as a first-line alternative or in combination with NSAIDs. 2, 5

Important Caveats and Contraindications

  • Avoid aspirin in analgesic doses during breastfeeding due to risk of salicylate intoxication and neonatal bleeding. 2

  • Opioids should not be used as default analgesics for breastfeeding mothers; they carry significantly higher risks of infant sedation, respiratory depression, and mortality compared with ketorolac and other NSAIDs. 2, 5

  • Follow standard NSAID contraindications: avoid in patients with active gastrointestinal bleeding, severe renal impairment, or hypersensitivity to NSAIDs. 4, 6

  • Limit duration of ketorolac therapy to minimize risk of adverse effects (gastrointestinal, renal, or bleeding complications increase with prolonged use beyond 5 days, especially in elderly patients—though this applies to maternal safety rather than infant exposure). 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safety of Ibuprofen and Paracetamol During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

IV Toradol Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safe Postpartum Medications for Breastfeeding Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.